{"name":"Delenex Therapeutics AG","slug":"delenex-therapeutics-ag","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"DLX105","genericName":"DLX105","slug":"dlx105","indication":"Other","status":"phase_2"}]},{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"DLX105 Hydrogel","genericName":"DLX105 Hydrogel","slug":"dlx105-hydrogel","indication":"Postoperative pain management","status":"phase_2"}]}],"pipeline":[{"name":"DLX105","genericName":"DLX105","slug":"dlx105","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"DLX105 Hydrogel","genericName":"DLX105 Hydrogel","slug":"dlx105-hydrogel","phase":"phase_2","mechanism":"DLX105 Hydrogel is a hydrogel formulation of a local anesthetic.","indications":["Postoperative pain management"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTE13SV8zNjlGYmRiOTBXZG1GSHpVWTZkSTRrQ05ZR1c5R2JPSkVQbHByYUJjcWpkZHR2TUZoY3FWOFJlbEpNaWh0LS1mS2ZjUENhZXVhUzEzRVVLSkRuYjBVSFhJbDZBNVlTb3JhRllnRQ?oc=5","date":"2012-07-04","type":"pipeline","source":"Wiley","summary":"Longitudinal Model-Based Meta-Analysis in Rheumatoid Arthritis: An Application Toward Model-Based Drug Development - Wiley","headline":"Longitudinal Model-Based Meta-Analysis in Rheumatoid Arthritis: An Application Toward Model-Based Drug Development","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":2},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}